Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inositol monophosphatase
(
IMPase
) is a crucial enzyme for the biosynthesis of phosphatidylinositol, an essential component in mycobacterial cell walls.
IMPase
A (ImpA) from
Mycobacterium smegmatis
is a bifunctional enzyme that also functions as a fructose-1,6-bisphosphatase (FBPase). To better understand the bifunctional nature of this enzyme, point mutagenesis was conducted on several key residues and their enzyme activity was tested. Our results along with active site models support the fact that ImpA is a bifunctional enzyme with residues Gly94, Thr95 hypothesized to be contributing to the FBPase activity and residues Trp220, Asp221 hypothesized to be contributing to the
IMPase
activity. Double mutants, W220A + D221A reduced both FBPase and
IMPase
activity drastically while the double mutant G94A + T95A surprisingly partially restored the
IMPase
activity compared to the single mutants. This study establishes the foundation toward obtaining a better understanding of the bifunctional nature of this enzyme.
ACS
Omega 2018 Oct 31
PMID:Inositol Monophosphatase: A Bifunctional Enzyme in
Mycobacterium smegmatis
. 3041 Oct 52